Search company, investor...

TUBE Pharmaceuticals

tubepharma.de

About TUBE Pharmaceuticals

TUBE Pharmaceuticals is a preclinical stage company developing tubulysins to treat cancer. It is based in Vienna, Austria.

Headquarters Location

Leberstr. 20

Vienna, 1110,

Austria

Missing: TUBE Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: TUBE Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

TUBE Pharmaceuticals Patents

TUBE Pharmaceuticals has filed 1 patent.

The 3 most popular patent topics include:

  • Abandoned drugs
  • Amines
  • Androgens and anabolic steroids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/21/2018

1/12/2021

Amines, Designer drugs, Ketones, Phenols, Ethers

Grant

Application Date

12/21/2018

Grant Date

1/12/2021

Title

Related Topics

Amines, Designer drugs, Ketones, Phenols, Ethers

Status

Grant

TUBE Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

TUBE Pharmaceuticals Rank

TUBE Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is TUBE Pharmaceuticals's headquarters?

    TUBE Pharmaceuticals's headquarters is located at Leberstr. 20, Vienna.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.